Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

INHIBITION OF MURINE CYTOCHROME P4501A BY TACRINE: IN VITRO STUDIES

Joanna Z. Peng, Rory P. Remmel and Ronald J. Sawchuk
Drug Metabolism and Disposition August 2004, 32 (8) 805-812; DOI: https://doi.org/10.1124/dmd.32.8.805
Joanna Z. Peng
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rory P. Remmel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ronald J. Sawchuk
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 32 no. 8 805-812
DOI 
https://doi.org/10.1124/dmd.32.8.805
PubMed 
15258105

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received January 7, 2004
  • Accepted April 23, 2004
  • Published online July 16, 2004.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Joanna Z. Peng1,
  2. Rory P. Remmel and
  3. Ronald J. Sawchuk
  1. Department of Pharmaceutics (J.Z.P, R.J.S.) and Department of Medicinal Chemistry (R.P.R.), College of Pharmacy, University of Minnesota, Minneapolis, Minnesota
  1. Address correspondence to:
    Dr. Ronald J. Sawchuk, Department of Pharmaceutics, College of Pharmacy, University of Minnesota, Weaver-Densford Hall, 308 Harvard Street S.E., Minneapolis, MN 55455. E-mail: sawch001{at}umn.edu
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2017 to January 2023

AbstractFullPdf
Aug 20170111
Sep 20170124
Oct 20170150
Nov 20172203
Dec 20170121
Jan 20180160
Feb 20180142
Mar 20180161
Apr 20181184
May 2018071
Jun 20181191
Jul 20180102
Aug 2018082
Sep 2018052
Oct 2018098
Nov 20180140
Dec 2018410
Jan 2019500
Feb 2019900
Mar 2019411
Apr 20191800
May 20191174
Jun 20191111
Jul 20191305
Aug 20192400
Oct 20191000
Nov 20192300
Dec 20191921
Jan 20201400
Feb 20201100
Mar 2020510
May 2020632
Jun 20201300
Jul 2020500
Aug 2020311
Sep 2020700
Oct 20201520
Nov 2020500
Dec 2020800
Jan 2021830
Feb 20211623
Mar 20211811
Apr 20214121
May 20211320
Jun 20211322
Jul 20211311
Aug 2021832
Sep 2021410
Oct 2021610
Nov 2021922
Dec 20211722
Jan 2022630
Feb 2022410
Mar 2022110
Apr 2022410
May 2022610
Jun 20221510
Jul 2022721
Aug 20221210
Sep 2022810
Oct 20221120
Nov 20221310
Dec 2022210
Jan 20231720

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 32 (8)
Drug Metabolism and Disposition
Vol. 32, Issue 8
1 Aug 2004
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
INHIBITION OF MURINE CYTOCHROME P4501A BY TACRINE: IN VITRO STUDIES
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

INHIBITION OF MURINE CYTOCHROME P4501A BY TACRINE: IN VITRO STUDIES

Joanna Z. Peng, Rory P. Remmel and Ronald J. Sawchuk
Drug Metabolism and Disposition August 1, 2004, 32 (8) 805-812; DOI: https://doi.org/10.1124/dmd.32.8.805

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

INHIBITION OF MURINE CYTOCHROME P4501A BY TACRINE: IN VITRO STUDIES

Joanna Z. Peng, Rory P. Remmel and Ronald J. Sawchuk
Drug Metabolism and Disposition August 1, 2004, 32 (8) 805-812; DOI: https://doi.org/10.1124/dmd.32.8.805
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Series-Compartment Models of Hepatic Elimination
  • Warfarin PBPK Model with TMDD Mechanism
  • Identification of payload-containing catabolites of ADCs
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics